Miguel Garcia, the CEO of Technophage S.A. and LxBio – Pharmaceuticals S.A., recently presented the Bio-Hub Project during the First Annual Meeting of Mobilizing and Green Agendas for Business Innovation, as part of the Recovery and Resilience Plan (PRR). The...
This week marked an important occasion as Technophage and VectorB2B – Drug Development joined forces for our annual Teambuilding event. Our destination was the picturesque town of Dornes, where a selection of thrilling team challenges awaited us. Both teams...
Last month Technophage team attended 33rd European Congress of Clinical Microbiology & Infectious Diseases with the clinical team from Israel, and Dr. Ran Nir-Paz from Hadassah Medical Center, presented the results obtained in the Phase I/IIa double-blinded,...
Technophage has been featured in ‘The Economist’ journal. The piece entitled ‘Western firms are becoming interested in a Soviet medicine’ describes how phage therapy is helping patients around the globe, highlighting the increased interest of western...
In the scope of the “Visit of delegation led by Chief Executive of Macao SAR and University of Macau Delegation to the University of Lisbon”, Technophage was invited to present the work that has been developed since 2014 in collaboration with the University of Macau....
Last month Technophage team attended ECCMID 2023, and together with the clinical team from Israel, we have presented the results from two cases of compassionate use carried out in Israel, under the supervision of Dra. Michal Deckel. – Case study 1 showed a...
